Clinical Trial Research Studies • Data Management • Electronic Data Capture (EDC) • eSource • CTMS
November 5
Clinical Trial Research Studies • Data Management • Electronic Data Capture (EDC) • eSource • CTMS
• Who We Are: • CRIO (Clinical Research IO) is a health tech company helping pharma, biotech, research sites, and academic research centers streamline regulatory workflows. • CRIO’s eSource and CTMS system is a leading, modern platform for clinical research. • In 2022, CRIO released its Reviewer product, allowing for thorough data review in eSource. • The Study Design Specialist creates comprehensive study builds from start to finish in the CRIO platform. • Responsibilities include developing eSource from protocols, conducting quality control reviews, and mentoring. • Join us at CRIO and be part of a dynamic team dedicated to revolutionizing the clinical research industry.
• Utilize protocols, eCRF guidelines, pharmacy manuals, lab manuals, and other source documents to produce comprehensive builds for clients. • Complete client-requested edits and customizations. • Manage complex trials to ensure all data is captured appropriately. • Modify standard templates to comply with protocol requirements. • Complete assignments on time. • Mentor and train current and new CRIO employees. • Experience with eSource and QC design in CRIO or other eSource/CTMS systems. • BS in medical or sciences field. • Experience as a Research Coordinator, Site Director, or Source Designer is a plus. • At least 1 year of healthcare experience. • Ability to interpret clinical trial protocols, and source documents. • Knowledge of medical terminology and procedures. • Strong people skills. • Detail-oriented with solid time management skills. • Well-organized, capable of establishing priorities, and executing tasks efficiently.
• This is a part time role: • Compensation Package - $20 an hour for all training and up to $450 for Study Design Build
Apply NowOctober 7
Part-time junior instructional designer for higher education clients at Nectar Inc.